Search
You can use the search box at the top to search by Author or content.
To search for a string, use speech marks: e.g. "string to search"
Displaying 121 - 140 of 851 records Index
Poster Brazilian guideline for lung cancer: recommendations and development process
2024 Prague [Global Evidence Summit]
OLIVEIRA, YUKARI, FARINASSO, FERREIRA, GARGANO, PRADO, Maior, ARAUJO, DE MELLO, ALVES OLIVEIRA JUNIOR, LUCCHETTA
"Background: Lung cancer accounted for 2.2 million new cases and 1.8 million fatalities in 2020, which made it the leading cause of cancer-related deaths (18%). The Brazilian Unified Health System (SUS) released the most recent edition of its lung cancer guidelines in 2014.
Objectives:…
Poster Brazilian national guideline for Alzheimer’s disease: recommendations and development process
2024 Prague [Global Evidence Summit]
DE PAULA, VISCONDI, AZEVEDO, FARINASSO, FERRI, BERTOLA, BRUCKI, Maior, ARAUJO, MELO, ALVES OLIVEIRA JUNIOR, LUCCHETTA
"Background: Globally, 50 million people suffer from dementia. The primary cause of dementia is Alzheimer's disease (AD), which accounts for up to 70% of cases worldwide and about 60% of cases in Brazil. The most recent version of Brazilian Unified Health System (SUS) AD guidelines dates…
Poster Brazilian national guideline for systemic arterial hypertension: recommendations and development process
2024 Prague [Global Evidence Summit]
LUCCHETTA, FERREIRA, Maior, Oliveira, DE BRITO, ALVES OLIVEIRA JUNIOR
"Background: Systemic arterial hypertension is a serious health condition with a worldwide prevalence of 1.3 billion between 30 and 79 years of age. In Brazil, despite the existence of official documents from the Ministry of Health (MoH), there is no clinical practice guideline (CPG) with…
Poster Brazilian private health insurance guidelines: implementing coverage criteria
2024 Prague [Global Evidence Summit]
FERREIRA, FACHI, GARGANO, OLIVEIRA, DE PAULA, FARINASSO, YUKARI, AZEVEDO, E MENEZES DE REZENDE, CECILIA DE SÁ CAMPELLO FAVERET, ALVES OLIVEIRA JUNIOR, LUCCHETTA
"Background: The National Supplementary Health Agency (ANS) regulates Brazil's private health insurance sector. Unlike established guidelines in the public health system, ANS has ""usage guidelines (DUT)"", which consider strict criteria, such as clinical condition,…
Poster Breakthroughs and challenges in conducting systematic reviews on rare diseases: implications of the ERNs Guidelines Programme
2024 Prague [Global Evidence Summit]
MARTÍN GÓMEZ, Isabel-Gómez, Pérez García, Vicente Edo, de Armas-Castellano, Trujillo-Martín, Godo Pla, Estrada Sabadell, Domínguez-García, Jausoro-Zubiaga, Blasco Amaro
"Background. The European Reference Networks (ERNs) Guidelines Programme aims to contribute to evidence-based clinical decision-making in rare diseases (RDs) through the development of clinical practice guidelines (CPGs) and other support tools. Methodologists and information specialists from…
Poster Bridging Gaps in Health Professional In-service Education: Harnessing Technology to improve accessibility and monitoring in Primary Care Training
2024 Prague [Global Evidence Summit]
Daniels, Ras, Cornick
Background:
The Practical Approach to Care Kit (PACK) is a strategy to streamline primary care (PC) delivery using evidence-informed clinical decision support, training and health system strengthening. South Africa’s department of health requires that 80% of nurses in PC receive PACK, and it has…
Poster Bridging the Gap: Empowering LMICs through Cochrane Evidence: Experiences of Cochrane Centers in Low- and Middle-Income Countries
2024 Prague [Global Evidence Summit]
Ashmawy, Armani, Rojas-Gómez, Widyaningsih, Gibbs, Kuriakose, Picón Jaimes, Judith Ho, Duque
Background
The demand for evidence-based healthcare worldwide highlights the need for Cochrane centers in LMICs, which face unique challenges such as limited resources and diverse populations.
Objectives
To describe strategies and challenges associated with establishing a Cochrane center in…
Poster Budget impact analysis in the Brazilian supplementary health care: developing an optimal spreadsheet
2024 Prague [Global Evidence Summit]
OLIVEIRA, GARGANO, FACHI, FERREIRA, DE PAULA, YUKARI, FARINASSO, AZEVEDO, E MENEZES DE REZENDE, CECILIA DE SÁ CAMPELLO FAVERET, ALVES OLIVEIRA JUNIOR, LUCCHETTA
"Background: The National Supplementary Health Agency (ANS) regulates Brazil's private health insurance sector, which covers approximately 26.3% of the population. Health insurance providers must cover a minimal range of medicines, devices, and medical procedures. This minimal list of…
Poster COBE: Advancing Evidence-Based Research Globally Through Collaboration and Innovation
2024 Prague [Global Evidence Summit]
Polmann, Meller Dias de Oliveira, Paz, Lemos, Pauletto, Massignan, Miron Stefani, De Luca Canto
"Background: The Brazilian Centre for Evidence-Based Research (COBE) was established at the Federal University of Santa Catarina, Brazil, in 2014, following the team leader’s postdoctoral fellowship at the Department of Dentistry, University of Alberta (UofA), Canada. Objective: COBE's…
Poster Can a generative AI chatbot answer citizens' questions on behalf of municipal employees?
2024 Prague [Global Evidence Summit]
Matsuki, Moriwaki, Takenami, Kitagawa
"Background: The adoption of generative AI, like ChatGPT, in government services is emerging as a solution to improve efficiency and accessibility in the public sector. These technologies promise to offset operational costs and extend service availability beyond traditional office hours.…
Poster Can artificial intelligence perform accurate peer review of literature search strategies? A proof-of-concept study
2024 Prague [Global Evidence Summit]
Hill, Brini, Tran, Morrison
Background: Presence of errors in search strategies affect the validity of findings in systematic reviews in public health. As many as 90% of search strategies in published systematic reviews contain at least one error with some reaching as high as 93% error rate in a single search. To mitigate…
Poster Can we GRADE chimeric-antigen-receptor T-cell therapies? The guideline development process of the Italian Society of Hematology.
2024 Prague [Global Evidence Summit]
MARCHETTI
"BACKGROUND:
Chimeric-antigen receptor T-cell therapies (CART) are autologus reingeneered lymphocytes campable of targeting neoplasic lymphoid cells and achieve a high rate of response in refractory/relapsed (R/R) large B-cell lymphomas (LBL) and mantle cell lymphomas (MCL). The economic and…
Poster Cannabis for medical purposes and Chronic Pain: Recommendations of an evidence based clinical practice guideline from the McMaster University
2024 Prague [Global Evidence Summit]
Darzi, Busse, Richards, Juurlink, Guyatt
Background:
People living with chronic pain increasingly use cannabis for therapeutic purposes; however, the benefits and harms remain uncertain.
Objective:
To provide recommendations for use of cannabis for therapeutic purposes in adults living with chronic pain.
Methods:
As per the GRADE…
Poster Capitalizing on global partnerships to build evidence-based practice expertise, synthesis and implementation in nursing academia
2024 Prague [Global Evidence Summit]
Morrison-Beedy, Tóthová, Chloubová, Dolák
"Background While there is overwhelming documentation that integrating evidence-based practice (EBP) in clinical settings improves healthcare quality, patient outcomes, and reduces costs, healthcare professions are still challenged with having sufficient educators and clinicians who are…
Poster Caracteristics and primary outcomes of clinical trials registries on COVID-19 vaccines A meta-research.
2024 Prague [Global Evidence Summit]
do Nascimento, Pacheco, de Toledo, Pasqui, Riera
Background: Although the speed of knowledge evolution is crucial in the context of a public health emergency, such as the COVID-19 pandemic, it is also essential that studies evaluating the effects of vaccines are well-planned, conducted and reported. Prioritizing methodological quality throughout…
Poster Cardiovascular risk in climacteric women: a need for a comprehensive guideline
2024 Prague [Global Evidence Summit]
Valsoler, Vanin, Dib, Stein
"Background:
Cardiovascular disease (CVD) is an essential concern in women's health, being the leading cause of mortality in postmenopausal women and significantly contributing to years of life lost and increased healthcare costs. Modifiable risk factors such as smoking, sedentary…
Poster Cardiovascular risk screening tools for athletes, a Scoping Review.
2024 Prague [Global Evidence Summit]
Chahin, Seron
"Background: To date, there is no compilation of screening tools for cardiovascular risk in athletes. Considering the risks of cardiovascular events associated with the practice of this physically and physiologically demanding sport, it is relevant to review the updated scientific evidence to…
Poster Caregiving Experience of Parents of Children with Tourette Syndrome: A Systematic Review and Meta-synthesis
2024 Prague [Global Evidence Summit]
Lee
Background: Tourette syndrome and comorbidities not only affect children's physical and mental health, but also interfere with their daily life and interpersonal interactions. While parents play a key role in assisting their children in symptom management, their experiences of caregiving…
Poster Causal Forest Analysis for Inclusive Evidence Generation and Informed Decision-Making in Development Interventions
2024 Prague [Global Evidence Summit]
Pandya, Kastel, Lakhote, Glandon
Background: The field of evidence-based policymaking has made considerable progress focusing on robust quantitative estimation of intervention effects. However, there is a growing recognition of the need to move beyond average treatment effects (ATE) and embrace a more nuanced understanding of…
Poster Challenges and strategies for implementing the STAR tool of comprehensive evaluation for guidelines: a qualitative study with Chinese physicians
2024 Prague [Global Evidence Summit]
Wang, Chen, Yang
"Background: The scientific, transparent and applicable rankings (STAR) working group has developed a new guideline evaluation tool and regularly conducts comprehensive evaluations of guidelines and consensus statements from China.
Objectives: In this study, we used qualitative interviews to…